Brief: Aarti Drugs Says Initiating Commercial Production Of Dermatology Product At Facility In Tarapur, Maharashtra
30/01/2024 15:29
Jan 30 (Reuters) - Aarti Drugs Ltd ADRG.NS :
* INITIATING COMMERCIAL PRODUCTION OF DERMATOLOGY PRODUCT AT
FACILITY IN TARAPUR, MAHARASHTRA
* TOTAL INVESTMENT REQUIREMENT 1.5-2 BILLION RUPEES
* FACILITY WILL HAVE TOTAL OPERATIONAL CAPACITY OF 24,000
MTPA
Source text for Eikon: ID:nBSE2h6p7B
Further company coverage: ADRG.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aarti Drugs
See all newsBrief: Aarti Drugs Says Adhish P. Patil Appointed MD For 5 Years From Oct 1
Brief: Aarti Drugs Posts June-Qtr Consol Net Profit 501.7 Million Rupees
Brief: Aarti Drugs March-Quarter Consol Profit 552.6 Million Rupees
Brief: Aarti Drugs Dividend 2 Rupees Per Share
Brief: Aarti Drugs Dec-Quarter Consol Net Profit 405.4 Million Rupees